JP2022507776A5 - - Google Patents
Info
- Publication number
- JP2022507776A5 JP2022507776A5 JP2021527829A JP2021527829A JP2022507776A5 JP 2022507776 A5 JP2022507776 A5 JP 2022507776A5 JP 2021527829 A JP2021527829 A JP 2021527829A JP 2021527829 A JP2021527829 A JP 2021527829A JP 2022507776 A5 JP2022507776 A5 JP 2022507776A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- group
- formula
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024152316A JP2025000636A (ja) | 2018-11-19 | 2024-09-04 | Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862769383P | 2018-11-19 | 2018-11-19 | |
| US62/769,383 | 2018-11-19 | ||
| PCT/US2019/062030 WO2020106627A1 (en) | 2018-11-19 | 2019-11-18 | C10-alkylene substituted 13-membered macrolides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152316A Division JP2025000636A (ja) | 2018-11-19 | 2024-09-04 | Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507776A JP2022507776A (ja) | 2022-01-18 |
| JP2022507776A5 true JP2022507776A5 (https=) | 2022-11-29 |
| JP7551610B2 JP7551610B2 (ja) | 2024-09-17 |
Family
ID=68916562
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527829A Active JP7551610B2 (ja) | 2018-11-19 | 2019-11-18 | Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用 |
| JP2024152316A Pending JP2025000636A (ja) | 2018-11-19 | 2024-09-04 | Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024152316A Pending JP2025000636A (ja) | 2018-11-19 | 2024-09-04 | Ｃ１０－アルキレン置換された１３員マクロライド及びそれらの使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US12552825B2 (https=) |
| EP (2) | EP4737470A2 (https=) |
| JP (2) | JP7551610B2 (https=) |
| KR (1) | KR102929869B1 (https=) |
| CN (1) | CN113573779A (https=) |
| AU (1) | AU2019385333B2 (https=) |
| BR (1) | BR112021009624A2 (https=) |
| CA (1) | CA3120148A1 (https=) |
| DK (1) | DK3883647T3 (https=) |
| ES (1) | ES3063764T3 (https=) |
| FI (1) | FI3883647T3 (https=) |
| IL (1) | IL283194B2 (https=) |
| LT (1) | LT3883647T (https=) |
| MX (1) | MX2021005423A (https=) |
| PT (1) | PT3883647T (https=) |
| SG (1) | SG11202105227QA (https=) |
| SI (1) | SI3883647T1 (https=) |
| SM (1) | SMT202600094T1 (https=) |
| WO (1) | WO2020106627A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202313065A (zh) * | 2021-05-28 | 2023-04-01 | 美商季卡尼醫療公司 | 用於治療遺傳疾病之化合物 |
| WO2023250513A1 (en) * | 2022-06-24 | 2023-12-28 | Zikani Therapeutics, Inc. | 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation |
| CN120152721A (zh) | 2022-09-01 | 2025-06-13 | 齐卡尼治疗股份有限公司 | 使用13元大环内酯治疗家族性腺瘤性息肉病 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
| NZ526120A (en) * | 1999-11-09 | 2005-02-25 | Pfizer Prod Inc | 13-membered azalides and their use as antibiotic agents |
| BR0110382A (pt) * | 2000-04-27 | 2003-06-24 | Pfizer Prod Inc | Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos |
| WO2003014136A1 (en) | 2001-08-08 | 2003-02-20 | Taisho Pharmaceutical Co., Ltd. | 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME |
| HRP20030381B1 (en) * | 2003-05-14 | 2007-05-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A |
| WO2004108744A2 (en) * | 2003-05-19 | 2004-12-16 | Prasad K Deshpande | Azalides and azaketolides having antimicrobial activity |
| WO2005042554A1 (en) * | 2003-10-30 | 2005-05-12 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| RU2008106915A (ru) * | 2005-07-26 | 2009-09-10 | Меркле Гмбх (De) | Макролидные конъюгаты пирролиновых и индолизиновых соединений |
| US8097708B2 (en) * | 2006-02-07 | 2012-01-17 | Taisho Pharmaceutical Co., Ltd. | 10a-Azalide compound |
| US20130102551A1 (en) * | 2010-07-01 | 2013-04-25 | Andreas Hotte | Antibiotic compositions |
| WO2013004116A1 (zh) * | 2011-07-06 | 2013-01-10 | 洛阳惠中兽药有限公司 | C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物 |
| JP6437523B2 (ja) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マクロライドならびにそれらの調製および使用の方法 |
| CN106998685A (zh) | 2014-10-08 | 2017-08-01 | 哈佛大学的校长及成员们 | 14‑元酮内酯及其制备和使用方法 |
| EP3273969A4 (en) * | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
| WO2016154533A1 (en) | 2015-03-25 | 2016-09-29 | President And Fellows Of Harvard College | Synthesis of desosamines |
| US20180273573A1 (en) * | 2015-10-01 | 2018-09-27 | Memorial Sloan-Kettering Cancer Center | Inhibitors of menaquinone biosynthesis |
| WO2018201076A2 (en) | 2017-04-28 | 2018-11-01 | Macrolide Pharmaceuticals Inc. | Macrolides with modified desosamine sugars and uses thereof |
-
2019
- 2019-11-18 DK DK19821351.4T patent/DK3883647T3/da active
- 2019-11-18 EP EP25226862.8A patent/EP4737470A2/en active Pending
- 2019-11-18 SG SG11202105227QA patent/SG11202105227QA/en unknown
- 2019-11-18 IL IL283194A patent/IL283194B2/en unknown
- 2019-11-18 CA CA3120148A patent/CA3120148A1/en active Pending
- 2019-11-18 LT LTEPPCT/US2019/062030T patent/LT3883647T/lt unknown
- 2019-11-18 SI SI201931026T patent/SI3883647T1/sl unknown
- 2019-11-18 BR BR112021009624-8A patent/BR112021009624A2/pt unknown
- 2019-11-18 KR KR1020217018876A patent/KR102929869B1/ko active Active
- 2019-11-18 ES ES19821351T patent/ES3063764T3/es active Active
- 2019-11-18 EP EP19821351.4A patent/EP3883647B1/en active Active
- 2019-11-18 FI FIEP19821351.4T patent/FI3883647T3/fi active
- 2019-11-18 CN CN201980086676.8A patent/CN113573779A/zh active Pending
- 2019-11-18 AU AU2019385333A patent/AU2019385333B2/en active Active
- 2019-11-18 PT PT198213514T patent/PT3883647T/pt unknown
- 2019-11-18 WO PCT/US2019/062030 patent/WO2020106627A1/en not_active Ceased
- 2019-11-18 JP JP2021527829A patent/JP7551610B2/ja active Active
- 2019-11-18 SM SM20260094T patent/SMT202600094T1/it unknown
- 2019-11-18 US US17/294,878 patent/US12552825B2/en active Active
- 2019-11-18 MX MX2021005423A patent/MX2021005423A/es unknown
-
2024
- 2024-09-04 JP JP2024152316A patent/JP2025000636A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2876690C (en) | Dihydropyrimidine compounds and their application in pharmaceuticals | |
| ES2967453T3 (es) | Compuestos de pirrolizina sustituidos y usos de los mismos | |
| EP2943481B1 (en) | (hetero)arylacetamide derivatives as antiretroviral agents | |
| JP2022507776A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| RU2626979C2 (ru) | Трициклические ингибиторы гиразы | |
| KR20190042667A (ko) | 테트라사이클린 화합물 및 치료 방법 | |
| BG93979A (bg) | Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им | |
| RS66126B1 (sr) | Makrociklična jedinjenja kao agonisti uboda i njihove metode i upotreba | |
| JO3271B1 (ar) | مشتقات الكوينولين المضادة للجراثيم | |
| JP2009535307A5 (https=) | ||
| NZ590126A (en) | Compounds having antiviral properties | |
| CA2831421A1 (en) | Novel cephalosporin derivatives and pharmaceutical compositions thereof | |
| JP2009538910A5 (https=) | ||
| US10144761B2 (en) | Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis | |
| CA2463544A1 (en) | Cross-linked glycopeptide-cephalosporin antibiotics | |
| TW452579B (en) | Antibacterial compounds | |
| JO2684B1 (en) | Quinoline antibacterial derivatives | |
| JP2022507795A5 (https=) | ||
| WO2023125825A1 (en) | Anticoronviral compounds and compositions and uses thereof | |
| US20240132480A1 (en) | Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase | |
| IN2014MN02364A (https=) | ||
| JO2725B1 (en) | Quinoline antibacterial derivatives | |
| MX2026002570A (es) | Compuestos de oxoisoindolinil piperidin-2,6-diona sustituida | |
| MX2025014137A (es) | Compuesto de oxoisoindolinil piperidin-2,6-diona sustituido como agente anticancerigeno |